Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002-2011 in Japan (JDDM32)

Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach: Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

(2012) S. E. Inzucchi et al.   DIABETES CARE

Impact of the Dipeptidyl Peptidase-4 Inhibitor Vildagliptin on Glucose Tolerance and β-Cell Function and Mass in Insulin Receptor Substrate-2-Knockout Mice Fed a High-Fat Diet

(2012) Koichiro Sato et al.   ENDOCRINOLOGY

Effects of long-term treatment with the dipeptidyl peptidase-4 inhibitor vildagliptin on islet endocrine cells in non-obese type 2 diabetic Goto-Kakizaki rats

(2012) Wataru Inaba et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

International clinical harmonization of glycated hemoglobin in Japan: From Japan Diabetes Society to National Glycohemoglobin Standardization Program values

(2012) Atsunori Kashiwagi et al.   Journal of Diabetes Investigation

Trends in drug prescriptions to diabetic patients from 2000 to 2008 in Italy's Lombardy Region: A large population-based study

(2011) Marta Baviera et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus

(2010) et al.   Journal of Diabetes Investigation

Trends in the prescription of anti-diabetic medications in the United Kingdom: a population-based analysis

(2009) Kristian B. Filion et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

National Trends in Treatment of Type 2 Diabetes Mellitus, 1994-2007

(2008) G. Caleb Alexander et al.   ARCHIVES OF INTERNAL MEDICINE

Prevalence and antihyperglycemic prescribing trends for patients with type 2 diabetes in Italy: A 4-year retrospective study from national primary care data

(2008) Giampiero Mazzaglia et al.   PHARMACOLOGICAL RESEARCH